Articles with public access mandates - Steven LipshultzLearn more
OverallNIHMRCNHMRCWellcomeNIHRGatesGovernment of SpainSNSFFCTNSFCBHFAHAAcademy of FinlandSwedish Research CouncilCIHRFRQSDFGWellcome Trust/DBT India AllianceESRCBMBFNSFDOEHewlettVAUSAIDIDRCDNRFINSERMVersus Arthritis, UKBBSRCCancer Research UKNRFDoris Duke Charitable FoundationPCORIGovernment of ItalyCGIARAXA Research Fund, FranceSusan G. Komen
Not available anywhere: 21
Intravenous pegylated asparaginase versus intramuscular native Escherichia coli L-asparaginase in newly diagnosed childhood acute lymphoblastic leukaemia (DFCI 05-001): a …
AE Place, KE Stevenson, LM Vrooman, MH Harris, SK Hunt, JE O'Brien, ...
The lancet oncology 16 (16), 1677-1690, 2015
Mandates: US National Institutes of Health
An analysis of energy-drink toxicity in the National Poison Data System
SM Seifert, SA Seifert, JL Schaechter, AC Bronstein, BE Benson, ...
Clinical toxicology 51 (7), 566-574, 2013
Mandates: US National Institutes of Health
Polymorphisms of ABCC5 and NOS3 genes influence doxorubicin cardiotoxicity in survivors of childhood acute lymphoblastic leukemia
M Krajinovic, J Elbared, S Drouin, L Bertout, A Rezgui, M Ansari, ...
The pharmacogenomics journal 16 (6), 530-535, 2016
Mandates: US National Institutes of Health, Canadian Institutes of Health Research
Exercise capacity in long‐term survivors of pediatric cancer: an analysis from the Cardiac Risk Factors in Childhood Cancer Survivors Study
AM Miller, G Lopez‐Mitnik, G Somarriba, SR Lipsitz, AS Hinkle, ...
Pediatric blood & cancer 60 (4), 663-668, 2013
Mandates: US National Institutes of Health
Cardiac complications in childhood cancer survivors treated with anthracyclines
VI Franco, SE Lipshultz
Cardiology in the Young 25 (S2), 107-116, 2015
Mandates: US National Institutes of Health
Risk factors for cardiovascular disease in children infected with human immunodeficiency virus-1
TL Miller, EJ Orav, SE Lipshultz, KL Arheart, C Duggan, GA Weinberg, ...
The Journal of pediatrics 153 (4), 491-497, 2008
Mandates: US National Institutes of Health
Dietary quality, caloric intake, and adiposity of childhood cancer survivors and their siblings: an analysis from the cardiac risk factors in childhood cancer survivors study
DC Landy, SR Lipsitz, JM Kurtz, AS Hinkle, LS Constine, MJ Adams, ...
Nutrition and cancer 65 (4), 547-555, 2013
Mandates: US National Institutes of Health
Dexrazoxane for reducing anthracycline-related cardiotoxicity in children with cancer: an update of the evidence
SE Lipshultz, VI Franco, SE Sallan, PC Adamson, RK Steiner, SM Swain, ...
Progress in Pediatric Cardiology 36 (1-2), 39-49, 2014
Mandates: US National Institutes of Health
A review of the preclinical development of dexrazoxane
EH Herman, BB Hasinoff, R Steiner, SE Lipshultz
Progress in Pediatric Cardiology 36 (1-2), 33-38, 2014
Mandates: Canadian Institutes of Health Research
Summary of the 2015 international paediatric heart failure summit of Johns Hopkins All Children’s Heart Institute
JP Jacobs, JA Quintessenza, TR Karl, A Asante-Korang, AD Everett, ...
Cardiology in the Young 25 (S2), 8-30, 2015
Mandates: US National Institutes of Health
Cardiotoxicity in pediatric lymphoma survivors
N Bansal, C Joshi, MJ Adams, K Hutchins, A Ray, SE Lipshultz
Expert Review of Cardiovascular Therapy 19 (11), 957-974, 2021
Mandates: US National Institutes of Health
Balancing the oncologic effectiveness versus the cardiotoxicity of anthracycline chemotherapy in childhood cancer
SD Colan, SE Lipshultz, SE Sallan
Progress in Pediatric Cardiology 36 (1-2), 7-10, 2014
Mandates: US National Institutes of Health
Peak oxygen consumption in Hodgkin's lymphoma survivors treated with mediastinal radiotherapy as a predictor of quality of life 5 years later
MJ Adams, AK Ng, P Mauch, SR Lipsitz, P Winters, SE Lipshultz
Progress in Pediatric Cardiology 39 (2), 93-98, 2015
Mandates: US National Institutes of Health
How do we improve the long-term consequences of cardiotoxicity in survivors of childhood cancer?
RK Steiner, VI Franco, SE Lipshultz
Progress in Pediatric Cardiology 36 (1-2), 27-30, 2014
Mandates: US National Institutes of Health
Dilated cardiomyopathy (primer)
S Heinz-Peter, F DeLisa, CA LP, E Felicitas, RE Hershberger, ...
Nature Reviews: Disease Primers 5 (1), 2019
Mandates: US National Institutes of Health, American Heart Association, German …
Do selection criteria for children with dilated cardiomyopathy enrolled in national registries explain differences in outcomes?
RG Weintraub, MD Everitt, PMA Alexander, JD Wilkinson, SE Lipshultz
Progress in Pediatric Cardiology 37 (1-2), 47-48, 2014
Mandates: US National Institutes of Health
Training pediatric cardiologists to meet the needs of patients with neurodevelopmental disorders
KM Clancy, SE Lipshultz
Progress in Pediatric Cardiology 44, 63-66, 2017
Mandates: US National Institutes of Health
Future research directions in pediatric cardiomyopathy
SE Lipshultz, WK Chung, JA Towbin, E Pahl, MD Everitt, CE Canter, ...
Progress in Pediatric Cardiology 40, 35-39, 2016
Mandates: US National Institutes of Health
Development and pilot evaluation of a new nanoparticle-capture workflow for doxorubicin-induced toxicity biomarker identification
EF Petricoin, MM Ross, W Zhou, D Tamburro, A Luchini, LA Liotta, ...
Progress in Pediatric Cardiology 39 (2), 85-91, 2015
Mandates: US National Institutes of Health
Lessons from the hearts of survivors of childhood cancer
LM Vrooman, SE Lipshultz, SE Sallan
Progress in Pediatric Cardiology 36 (1-2), 51-55, 2014
Mandates: US National Institutes of Health
Publication and funding information is determined automatically by a computer program